SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $958,000 | -10.6% | 33,123 | 0.0% | 0.65% | +6.8% |
| Q1 2022 | $1,071,000 | +16.2% | 33,123 | +4.8% | 0.60% | +21.5% |
| Q4 2021 | $922,000 | +9.4% | 31,618 | 0.0% | 0.50% | +1.0% |
| Q3 2021 | $843,000 | +50.0% | 31,618 | +73.1% | 0.49% | +53.6% |
| Q2 2021 | $562,000 | +20.6% | 18,265 | +2.6% | 0.32% | +13.0% |
| Q1 2021 | $466,000 | +4.0% | 17,806 | 0.0% | 0.28% | -17.9% |
| Q4 2020 | $448,000 | – | 17,806 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |